Emerging in the landscape of weight management treatment, retatrutide represents a different approach. Different from many available medications, retatrutide operates as a double agonist, simultaneously engaging both glucagon-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) binding sites. This dual engagement promotes s… Read More